Leading cancer expert says recent study adds further support for a randomised clinical trial of aspirin for cancer prevention. New research published in Acta Obstetricia et Gynecologica Scandinavica, a journal of the Nordic Federation of Societies of Obstetrics and Gynecology, showed regular aspirin may decrease the risk of ovarian cancer. Ovarian Cancer is the ninth most…
Details
Federal Minister launches ASPREE in Adelaide The Hon Mark Butler MP, Minister for Mental Health and Ageing described the ASPREE study as an incredibly important piece of medical research during the official opening of the new clinical centre in Adelaide on September 21, 2012. He said the ASPREE study ticked a number of boxes: it addressed…
Details
Humble hero or hidden villain? The ongoing story of aspirin’s powers. by Professor Andrew Tonkin The humble aspirin has a remarkable history dating back to ancient Egyptian times when the bark of weeping willow (which contains salicin from which the aspirin formulation is derived) was found to have anti-inflammatory properties. And Hippocrates wrote about the…
Details
A Lovely Surprise
We love to hear from ASPREE participants. Your letters share thoughtful suggestions, compliments, comments and questions.
And then there are notes, like this one “Wishing you and yours a happy day.” returned with an ALSOP questionnaire, which simply brightens our day.
Thank you.
Bendigo’s postive and active ageing newsetter ‘Zoom’, features a story on ASPREE’s Lynn O’Neill and her incredible knitting skills this month. Lynn moved from Melbourne to Central Victoria in late 2010, a move she hasn’t regretted. Read her story from Issue 3 Spring 2012 here: There was a time when local nurse Lynn O’Neill’s dream…
Details
Congratulations to the hardworking Biobank team and to 5,000 wonderful ASPREE participants. Together, we’ve reached the half way mark on this very important, world first, Healthy Ageing Biobank study. Many Biobank participants will be familiar with the ASPREE BioBus, a specially fitted mobile laboratory that enables participants in regional and rural Victoria, NSW and Tasmania to participate…
DetailsOver 150 people marked the 500th participant in the ACT to be enrolled in the healthy ageing study, ASPREE (ASPirin in Reducing Events in the Elderly) at a morning tea in Canberra today. ASPREE, the largest ever primary prevention aspirin study in Australians aged 70 and over, is investigating whether aspirin can delay or prevent the…
Details
We’d love you to follow our progress on @ASPREE_aus What is twitter? It’s an online service that allows people to send messages limited to 140 characters per entry. The summary-like messages are instant and sent to those who follow you. Millions of people around the world have a twitter account. While we will be tweeting about ASPREE events…
Details
Senior ASPREE investigator, Professor Mark Nelson says a recent paper that links taking NSAID (Non Steroidal Anti-inflammatory Drugs) to a decrease in the risk of developing skin cancer underscores the importance of the ASPREE study. “We welcome the findings of this study as the possibility of aspirin having cancer preventing properties is one of the rationales…
DetailsPopular morning radio personalities Ross and John on Melbourne radio station 3AW, interviewed Prof Andrew Tonkin, ASPREE senior investigator and Head of Cardiovascular Research Unit, Monash University about aspirin and the ASPREE trial. Hear Andrew discuss the pros and cons of aspirin and what the ASPREE study is really about. Click here to listen (run time…
Details© 2015 All Rights Reserved. • Monash University, Department of Epidemiology and Preventive Medicine | Disclaimer & Privacy